A novel NF-κB inhibitor, DHMEQ, ameliorates pristane-induced lupus in mice

Nuclear factor (NF)-κB is strongly associated with the development of immune regulation and inflammation. The aim of the present study was to identify whether a NF-κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), ameliorates systemic lupus erythematosus (SLE) in a pristane-induced mouse model....

Descripción completa

Detalles Bibliográficos
Autores principales: QU, HUIQING, BIAN, WEIHUA, XU, YANYAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061236/
https://www.ncbi.nlm.nih.gov/pubmed/24944605
http://dx.doi.org/10.3892/etm.2014.1718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061236/
https://www.ncbi.nlm.nih.gov/pubmed/24944605
http://dx.doi.org/10.3892/etm.2014.1718

Ejemplares similares